Jeffrey P. Hank - 15 Nov 2024 Form 4 Insider Report for QUALYS, INC. (QLYS)

Role
Director
Signature
/s/ Bruce Posey, by power of attorney
Issuer symbol
QLYS
Transactions as of
15 Nov 2024
Net transactions value
-$585,251
Form type
4
Filing time
18 Nov 2024, 17:30:36 UTC
Previous filing
14 Jun 2024
Next filing
06 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QLYS Common Stock Options Exercise $162,720 +4,000 +32% $40.68 16,666 15 Nov 2024 Direct F1
transaction QLYS Common Stock Sale $232,192 -1,594 -9.6% $145.67 15,072 15 Nov 2024 Direct F1, F2
transaction QLYS Common Stock Sale $264,607 -1,806 -12% $146.52 13,266 15 Nov 2024 Direct F1, F3
transaction QLYS Common Stock Sale $88,304 -599 -4.5% $147.42 12,667 15 Nov 2024 Direct F1, F4
transaction QLYS Common Stock Sale $148 -1 -0.01% $148.11 12,666 15 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QLYS Stock Option (right to buy) Options Exercise $162,720 -4,000 -50% $40.68 4,000 15 Nov 2024 Common Stock 4,000 $40.68 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024.
F2 The sale price represents the weighted average price of the shares sold ranging from $145.02 to $146.00 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 The sale price represents the weighted average price of the shares sold ranging from $146.03 to $147.01 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4 The sale price represents the weighted average price of the shares sold ranging from $147.09 to $148.07 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5 This option is fully vested and immediately exercisable.